| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 151.91B | 149.90B | 137.59B | 137.48B | 121.84B | 187.70B |
| Gross Profit | 14.68B | 14.66B | 13.37B | 13.16B | 12.51B | 11.70B |
| EBITDA | 5.43B | 5.58B | 4.74B | 4.26B | 4.16B | 3.75B |
| Net Income | 2.71B | 2.90B | 2.13B | 1.39B | 1.15B | 1.26B |
Balance Sheet | ||||||
| Total Assets | 76.42B | 74.76B | 78.42B | 73.29B | 71.61B | 68.86B |
| Cash, Cash Equivalents and Short-Term Investments | 6.08B | 5.53B | 7.11B | 8.36B | 7.54B | 9.59B |
| Total Debt | 21.09B | 20.30B | 25.41B | 28.84B | 25.45B | 25.34B |
| Total Liabilities | 42.41B | 40.95B | 47.41B | 47.17B | 42.58B | 41.61B |
| Stockholders Equity | 32.27B | 32.04B | 29.33B | 24.48B | 24.43B | 23.15B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.41B | 3.12B | 2.62B | -2.66B | 4.12B |
| Operating Cash Flow | 0.00 | 3.92B | 3.59B | 3.34B | -814.00M | 5.42B |
| Investing Cash Flow | 0.00 | 397.00M | -637.00M | -666.00M | -795.00M | -1.83B |
| Financing Cash Flow | 0.00 | -5.89B | -4.21B | -1.86B | -453.00M | -1.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥32.81B | 9.72 | ― | 1.94% | 3.15% | 27.71% | |
69 Neutral | ¥164.93B | 9.61 | ― | 1.39% | 3.91% | -0.28% | |
68 Neutral | ¥16.78B | 2.44 | ― | 3.17% | 5.19% | 11.04% | |
65 Neutral | ¥29.68B | 10.33 | ― | 3.23% | -0.31% | -37.42% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥48.53B | 3.77 | ― | 0.52% | 20.97% | -56.39% | |
61 Neutral | ¥9.03B | 12.72 | ― | 0.95% | 6.26% | 67.81% |